332 related articles for article (PubMed ID: 32005234)
1. TRIM21-SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis.
Zhang P; Li X; He Q; Zhang L; Song K; Yang X; He Q; Wang Y; Hong X; Ma J; Liu N
J Biomed Sci; 2020 Jan; 27(1):30. PubMed ID: 32005234
[TBL] [Abstract][Full Text] [Related]
2. FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination.
Shi S; Zhang Q; Zhang K; Chen W; Xie H; Pan S; Xue Z; You B; Zhao J; You Y
Cell Oncol (Dordr); 2024 Feb; 47(1):283-301. PubMed ID: 37782406
[TBL] [Abstract][Full Text] [Related]
3. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.
Li JY; Zhao Y; Gong S; Wang MM; Liu X; He QM; Li YQ; Huang SY; Qiao H; Tan XR; Ye ML; Zhu XH; He SW; Li Q; Liang YL; Chen KL; Huang SW; Li QJ; Ma J; Liu N
Nat Commun; 2023 Feb; 14(1):865. PubMed ID: 36797289
[TBL] [Abstract][Full Text] [Related]
4. WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma.
Zhao Y; Li WF; Li QJ; He SW; He QM; Long LF; Liu N; Ma J
Oral Oncol; 2021 Nov; 122():105576. PubMed ID: 34689010
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
6. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.
Miao J; Chen B; Xiao Y; Huang R; Xiao X; Lu S; Zhang L; Wang X; Ouyang Y; Chen X; Chen Q; Xiang Y; Guo X; Deng X; Wang L; Mai H; Zhao C
Cancer Gene Ther; 2023 Sep; 30(9):1249-1259. PubMed ID: 37258811
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.
Long Z; Wang B; Tao D; Huang Y; Tao Z
Int J Mol Med; 2014 Nov; 34(5):1388-94. PubMed ID: 25231528
[TBL] [Abstract][Full Text] [Related]
9. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization.
Reddy BA; van der Knaap JA; Bot AG; Mohd-Sarip A; Dekkers DH; Timmermans MA; Martens JW; Demmers JA; Verrijzer CP
Mol Cell; 2014 Feb; 53(3):458-70. PubMed ID: 24462112
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
[TBL] [Abstract][Full Text] [Related]
13. The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53.
Su X; Feng C; Wang S; Shi L; Gu Q; Zhang H; Lan X; Zhao Y; Qiang W; Ji M; Hou P
Cell Death Differ; 2021 Aug; 28(8):2450-2464. PubMed ID: 33742136
[TBL] [Abstract][Full Text] [Related]
14. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
[TBL] [Abstract][Full Text] [Related]
15. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
[TBL] [Abstract][Full Text] [Related]
16. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.
Liao L; Yan WJ; Tian CM; Li MY; Tian YQ; Zeng GQ
Technol Cancer Res Treat; 2018 Jan; 17():1533034617750309. PubMed ID: 29357787
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
[TBL] [Abstract][Full Text] [Related]
20. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
